Insera Therapeutics is a Sacramento, CA based medical devices company. Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year.

2019-04-10 · Sacramento-based Insera Therapeutics Inc. says it's ready to ramp up to commercialization now that it has approval to bring its medical device to Europe.

CLEARTM stands for Customizable, Luminal, Evacuation, Aspiration, and Retrieval. The CLEARTM Aspiration System is currently not cleared to market in the United States. 2010-06-09 Find 27 listings related to Insera Therapeutics Llc in Sacramento on YP.com. See reviews, photos, directions, phone numbers and more for Insera Therapeutics Llc locations in Sacramento, CA. Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to … To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting.

20090198269: Device for the Removal of Thrombi From Blood Vessels: August, 2009: Hannes et al. 7572290 About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal Find company research, competitor information, contact details & financial data for Insera Therapeutics LLC of Sacramento, CA. Get the latest business insights from Dun & Bradstreet. SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever. US-based medical devices firm Insera Therapeutics has received Conformité Européenne (CE) mark approval for its CLEAR Aspiration System, a cyclical-suction stroke thrombectomy platform. Image: CT scan of brain with red area showing hemorrhagic stroke or ischemic stroke.

Insera Therapeutics is a Sacramento, CA based medical devices company. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making.

Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases . Private/Public: private Phone: 415-895-0945 Email: [email protected]

Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases. WHAT WE DO Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Interested in knowing more about our innovative products and services?

Applicant: Insera Therapeutics, Inc. Abstract: Methods of providing embolic protection during treatment of a vessel include advancing a microcatheter in the vessel, inserting a textile structure in a collapsed state into the microcatheter, and advancing the textile structure through the microcatheter.

Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Insera Therapeutics, Inc. United States of America Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases 2019-04-10 · Sacramento-based Insera Therapeutics Inc. says it's ready to ramp up to commercialization now that it has approval to bring its medical device to Europe. Insera Therapeutics was a finalist at the 2018 Sacramento Innovation Awards. This video highlights the CLEAR Aspiration System. CLEAR aspiration system (Insera Therapeutics) Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last month, the first two stroke patients were treated using the same platform. Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR.

The CLEARTM Aspiration System is currently not cleared to market in the United States. 2010-06-09 Find 27 listings related to Insera Therapeutics Llc in Sacramento on YP.com. See reviews, photos, directions, phone numbers and more for Insera Therapeutics Llc locations in Sacramento, CA. Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to … To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting.
Täby fotboll herr

Insera Therapeutics is a Sacramento, CA based medical devices company. Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to take suction aspiration to a new level.

InnovatorMD's mission is to globally advance the work of physician innovators and entrepreneurs delivering solutions that revolutionize patient care. Insera Therapeutics doesn't have any recent trademark applications, indicating Insera Therapeutics is focusing on its existing business rather than expanding into new products and markets.
Diversified portfolio percentages

infor lyckta dorrar
biblioteket skarholmen
alla kan dartmouth
movant malmö
cbct röntgen

1 Co-Founder and CEO of Gladiator Therapeutics, Bill Grovatt, and the Inventor and Scientist behind the patented ceramics used in the Insera Therapeutics.

20090209855: MEDICAL DEVICES FOR TREATING A TARGET SITE AND ASSOCIATED METHOD: August, 2009: Drilling et al.

[Intervju med National Science Foundation's Small Business Expert] Insera Therapeutics Insera Therapeutics. Vetenskap och affärer går inte alltid hand i hand.

This video highlights the CLEAR Aspiration System. CLEAR aspiration system (Insera Therapeutics) Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last month, the first two stroke patients were treated using the same platform.

The system is designed for blood clots and has been indicated for use in patients who have acute ischemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis … Insera Therapeutics has announced that the first two ischaemic stroke patients have been treated with its flagship cyclic aspiration system, CLEAR. The company received CE mark approval for its flagship product, the CLEAR Aspiration System, in March 2019.